Kymanox

Arizona City, United States Founded: 2000 • Age: 26 yrs Acquired By Kymanox
Regulatory, training, and market access consulting services are offered.

About Kymanox

Kymanox is a Healthcare company based in Arizona City (United States) founded in 2000, and was acquired by Kymanox in March 2023. Regulatory, training, and market access consulting services are offered. It operates on a Professional Services model. Kymanox offers products and services including Human Factors Engineering, Regulatory Strategy and Consulting, and Instructional Labeling and Training. Its focus areas include Medical Devices and Human Factors Engineering. Its legal entity is Kymanox Corporation. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.

Company details

Kymanox is involved in providing Human Factors Engineering services for medical devices and pharmaceuticals. Comprehensive solutions are offered across product development lifecycles, focusing on usability engineering, regulatory compliance, and risk management. Services are extended to various sectors including combination products, biotechnology, and diagnostics. Innovative approaches are integrated to enhance user experiences and improve healthcare outcomes. Support is also provided for instructional labeling, training, and regulatory strategy to ensure compliance with industry standards.

  • Headquarters Arizona City, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    •••• ••••
  • Website agilisconsulting.com
  • Social LinkedIn
  • Acquired by Kymanox (Mar 2023)
  • Legal Name Kymanox Corporation
Key Metrics

Products & Services of Kymanox

Kymanox offers a comprehensive portfolio of products and services, including Human Factors Engineering, Regulatory Strategy and Consulting, and Instructional Labeling and Training.

Human Factors Engineering
Engineering Services

Human Factors Engineering is provided for product usability.

Regulatory Strategy and Consulting
Consulting Services

Regulatory guidance is offered for compliance with standards.

Instructional Labeling and Training
Training Services

Labeling and training are developed for user performance.

Investors in Kymanox

Kymanox has secured backing from 1 investor. Prominent investors backing the company include Kymanox.

All
InvestorDescriptionFounded YearDomainLocation
Commercialization, validation, and consulting services for vital medicines are provided.
2004kymanox.comMorrisville, United States
Premium access

Investor details for Kymanox

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Kymanox

2 dated milestones of Kymanox across 23 years, from founding to its latest funding, stage changes and deals.

  1. Founded Kymanox is founded.
  2. Exit Acquired by Kymanox.

Competitors of Kymanox

Kymanox has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indegene.com1998Princeton, United States$220M350
Suite solutions are provided for payers and healthcare providers.
integrichain.com2005Philadelphia, United States$2M320
Inventory, order and customer relationship management solution for life science suppliers.
clearviewhcp.com2008Newton, United States381
Strategic consulting services are provided to life sciences companies.
Premium access

Detailed competitors of Kymanox

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Kymanox (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Kymanox

Premium access

Complete news archive for Kymanox

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kymanox

Kymanox was founded in 2000.

Kymanox is headquartered in Arizona City, United States. It is registered at Arizona City, Arizona, United States.

Kymanox is involved in providing Human Factors Engineering services for medical devices and pharmaceuticals. Comprehensive solutions are offered across product development lifecycles, focusing on usability engineering, regulatory compliance, and risk management. Services are extended to various sectors including combination products, biotechnology, and diagnostics. Innovative approaches are integrated to enhance user experiences and improve healthcare outcomes. Support is also provided for instructional labeling, training, and regulatory strategy to ensure compliance with industry standards.

Kymanox's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.

Kymanox offers Human Factors Engineering, Regulatory Strategy and Consulting, and Instructional Labeling and Training.

Kymanox has 1 investor. Key investors include Kymanox.

Kymanox operates through Kymanox Corporation.

Yes. Kymanox was acquired by Kymanox in March 2023.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available